Cardiovascular Endocrinology and Metabolism: Theory and Practice of Cardiometabolic Medicine

— —

Andrew J. Krentz (Visiting Professor, Institute of Cardiovascular and Metabolic Research, University of Reading, UK) Robert J. Chilton (Professor, Department of Medicine, Division of Cardiology, University of Texas, San Antonio, USA)

Cardiovascular Endocrinology and Metabolism

Theory and Practice of Cardiometabolic Medicine

Andrew J. Krentz (Visiting Professor, Institute of Cardiovascular and Metabolic Research, University of Reading, UK), Robert J. Chilton (Professor, Department of Medicine, Division of Cardiology, University of Texas, San Antonio, USA)

$275.95

Paperback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Academic Press Inc
28 March 2023

Cardiovascular medicine; Diabetes

Cardiovascular Endocrinology and Metabolism: Theory and Practice of Cardiometabolic Medicine discusses the close intersection between metabolic disorders and cardiovascular disease, covering the basic science and pathophysiology of disease and the latest research in pharmacological approaches and translational therapeutic options. This book is a valuable resource for the vascular and endocrinology clinical and research communities in need of knowledge and potential outcomes.

The global increase in the prevalence of cardiometabolic disorders, and the introduction of therapeutic options for treating metabolic disease that also lower cardiovascular risk, is bringing endocrinologists and cardiologists together in a shared clinical experience.

Edited by: Andrew J. Krentz (Visiting Professor Institute of Cardiovascular and Metabolic Research University of Reading UK), Robert J. Chilton (Professor, Department of Medicine, Division of Cardiology, University of Texas, San Antonio, USA)
Imprint: Academic Press Inc
Country of Publication: United Kingdom
Dimensions: Height: 235mm, Width: 191mm,
Weight: 1.110kg
ISBN: 9780323999915
ISBN 10: 0323999913
Pages: 530
Publication Date: 28 March 2023
Audience: Professional and scholarly , Undergraduate
Format: Paperback
Publisher's Status: Active

Part 1. Basic science and pathophysiology 1. Obesity and insulin resistance 2. Diabetes and macrovascular disease: epidemiology and cardiovascular risk assessment 3. Hypertension 4. Lipid metabolism: role in atherogenesis 5. Renal disease and cardiorenal interactions 6. NAFLD/NASH and cardiovascular risk 7. Heart failure 8. Prothrombosis: association with cardiometabolic disease 9. Inflammation, metabolism and cardiovascular disease 10. Classic endocrine disorders: association with vascular disease Part 2. Clinical evaluation, lifestyle measures and therapeutic options 11. Non-pharmacological strategies in the prevention and management of cardiometabolic disease 12. Obesity: pharmacological approaches to prevention and management 13. Diabetes: evolution of multifactorial vascular risk reduction 14. Diabetes CVOTS: design, interpretation and future directions 15. Novel glucose-lowering drugs: a new era of cardioprotection and renoprotection 16: Hypertension: pharmacological and surgical management 17. PCSK-9 inhibitors and other novel lipid-modifying drugs 18. Recent therapeutic developments in heart failure 19. Antiplatelet agents 20. Progress in anticoagulant therapy 21. Invasive treatment of atherosclerotic cardiovascular disease: today and tomorrow 22. Cardiometabolic medicine in practice: role of cardiologists vs endocrinologists and the need for a new clinical specialty

Andrew Krentz has four decades of clinical and translational research experience in metabolic, endocrine and related cardiovascular disorders. His expertise in the life sciences includes preclinical and early-phase clinical drug development; he has personally contributed translational medical innovations to endocrinology clinical practice. He is actively involved in projects focused on precision diagnostics and therapeutics, digital healthcare, and healthy longevity that bridge the academic-industry spaces. Beyond his expertise in diabetes and endocrinology, he is accredited as a clinical specialist by the European Society for Hypertension and is a member of the Medical, Scientific & Research Committee of Heart UK. He is President-Elect of the Vascular, Lipid & Metabolism section of the Royal Society of Medicine as well as being a member of the European Group for the Study of Insulin Resistance (EGIR) and the Diabetes & Cardiovascular Study Group of the European Association for the Study of Diabetes (EASD). He has authored more than 200 scientific publications and founded the journal Cardiovascular Endocrinology & Metabolism and serves as Editor-in-Chief. Robert J. Chilton, DO, is a Clinical Professor of Medicine, Director of the Cardiac Catheterization Laboratory at University Hospital and the Audie L. Murphy VA Hospital, and Associate Program Director of the Interventional Cardiology Fellowship Program. A fellow of the American College of Cardiology, American College of Physicians, American College of Osteopathic Internists, and American Heart Association, Dr. Chilton also chairs the Electrophysiology Board Examination for the American Osteopathic Association and presides over the San Antonio chapters of both the Cardiovascular Society and American Heart Association. Over the past 20 years, Dr. Chilton has authored numerous articles, book chapters, abstracts, and presentations on cardiology. He has developed educational materials and has lectured widely, garnering several awards for his academic contributions, including 1994 Outstanding Teacher from the UT San Antonio.